文献速递痛风与晶体性关节病

加拿大安大略省痛风急性发作患者急诊就诊的医疗使用情况:基于人群的健康系统分析

Health Care Use Among Patients Presenting to Emergency Department for Gout Flares in Ontario, Canada: A Population-Based Health Systems Analysis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2026-05-11

该研究基于加拿大安大略省2014至2023年人群数据,分析125,505次痛风急诊就诊的特征与医疗使用模式。结果显示急诊痛风就诊负担高,发作后随访与降尿酸管理不足,90天内重复急诊就诊率达29.9%。

要点

  • 2014至2023年共125,505次痛风急诊就诊,其中69.2%为新发急诊病例,男性占77.5%。
  • 急诊就诊后30天内仅21.3%有痛风特异性随访,6个月内仅38.1%接受门诊血尿酸检测。
  • 90天内29.9%再次急诊就诊,其中9.4%为痛风相关,提示急诊后管理不足。

核心结论

  • 痛风导致高负担的急诊就诊,且治疗不理想、随访差、重复就诊频繁,需要质量改进以预防急性就诊并改善急诊后管理。

研究设计与样本

  • 基于加拿大安大略省2014至2023年的人群基础研究,分析急诊痛风就诊的患者特征、就诊率趋势及医疗使用模式。
  • 共纳入125,505次急诊痛风就诊,其中86,824次(69.2%)为新发急诊病例。
  • 对年龄≥66岁者分析了痛风相关药物使用情况。

主要发现

  • 急诊痛风就诊者平均年龄59.7岁,男性占77.5%,更多居住于物质剥夺程度较高且种族多样性较低的社区。
  • 合并症负担高,以高血压(57.7%)和糖尿病(24.0%)为主。
  • 急诊痛风就诊在2018年达峰,粗年率为每1,000人0.99次(95%CI 0.97-1.01),男性为1.56次(95%CI 1.53-1.59)。
  • 75-84岁老年人在2015年就诊率最高,为每1,000人3.01次(95%CI 2.89-3.15)。
  • 急诊出院后30天内,21.3%有痛风特异性随访,≥66岁者中28.3%接受发作期药物,10.3%填写阿片类药物处方;6个月内38.1%接受门诊血尿酸检测;90天内29.9%再次急诊就诊,其中9.4%为痛风相关。

关键数值与推荐

  • 急诊痛风粗年率峰值(2018年)为每1,000人0.99次(95%CI 0.97-1.01),男性为1.56次(95%CI 1.53-1.59)。
  • 75-84岁人群2015年就诊率最高,为每1,000人3.01次(95%CI 2.89-3.15)。
  • 急诊出院后30天内痛风特异性随访率为21.3%,≥66岁者发作期药物使用率为28.3%,阿片类药物处方填写率为10.3%。
  • 6个月内门诊血尿酸检测率为38.1%,90天内重复急诊就诊率为29.9%(痛风相关为9.4%)。

临床怎么用

  • 风湿免疫科应关注痛风急诊就诊后的衔接管理,提高痛风特异性随访和门诊血尿酸检测率。
  • 对≥66岁痛风急诊患者,需评估发作期药物使用及阿片类药物处方情况,优化急性期治疗。
  • 针对高重复急诊就诊率,应建立急诊后降尿酸治疗与随访路径以减少急性 care 需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We characterized emergency department (ED) gout visits and identified patient characteristics and health services patterns contributing to ED presentations. METHODS: We conducted a population-based study of ED gout visits in Ontario, Canada, between 2014 and 2023. We assessed patient characteristics, encounter rate trends (cumulatively and stratified by age and sex), and health care use surrounding ED visits. Among individuals aged ≥66 years old, gout-related medication use was examined. RESULTS: From 2014 to 2023, 125,505 ED gout visits occurred, including 86,824 (69.2%) incident ED cases. Mean age was 59.7 years, with 77.5% men. Individuals with ED gout visits were more likely to live in materially marginalized and less racially diverse neighborhoods. Comorbidity burden was high, driven by hypertension (57.7%) and diabetes (24.0%). ED gout encounters peaked in 2018, with an annual crude rate of 0.99 visits per 1,000 persons (95% confidence interval [CI] 0.97-1.01) and a male-specific rate of 1.56 (95% CI 1.53-1.59). Older adults (aged 75-84 years) had the highest rates at 3.01 (95% CI 2.89-3.15) visits per 1,000 persons in 2015 across study years. Within 30 days of ED discharge, 21.3% had gout-specific follow-up visits, 28.3% of patients aged ≥66 years old received flare medications, and 10.3% filled an opioid prescription. By six months, 38.1% underwent outpatient serum urate testing. Within 90 days, repeat ED visits occurred in 29.9%, with 9.4% specifically for gout. CONCLUSION: Gout contributes to a high burden of ED visits, with suboptimal treatment, poor follow-up, and frequent representations. Quality improvement efforts are needed to prevent acute care presentations for gout and improve post-ED management.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Kwok TSH, Morais S, Silverstein WK, et al. Health Care Use Among Patients Presenting to Emergency Department for Gout Flares in Ontario, Canada: A Population-Based Health Systems Analysis. Arthritis Care Res (Hoboken). 2026. PMID: 42112851. doi:10.1002/acr.80086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。